Reactive arthritis can involve characteristic cutaneous features alongside joint inflammation. When psoriasiform skin lesions or circinate balanitis are present, the clinical approach must address both the articular and dermatological components of the disease.
This protocol is specific to reactive arthritis presenting with psoriasiform skin lesions or circinate balanitis. These skin manifestations are recognised features of the condition and are typically evaluated alongside the joint presentation. Topical approaches are commonly considered as an initial management strategy for these cutaneous findings.
When skin involvement is more severe, a systemic agent may be required to control disease manifestations. The structured protocol specifies which agents are indicated and under what clinical conditions.
Full regimen details available in the protocol below …Skin manifestations, such as psoriasiform lesions and circinate balanitis, usually respond well to topical glucocorticoid treatment with or without keratolytic agents.
In the case of more severe manifestations, methotrexate or retinoid agents may control the disease manifestations.